Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
Active agent against cancer metastasis discovered: Adhibin prevents migration and attachment to other cells
Every cell in the body normally has its fixed place as part of a tissue structure. Except for a few cell types, such as blood ...
The American Journal of Managed Care9h
How Prior Malignancy Impacts Survival in Metastatic Colorectal Cancer
New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...
Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer
The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...
precisionmedicineonline1d
Merck Talks Up Pipeline Diversification as Demand for Keytruda, Facing Patent Expirations, Grows
The company's blockbuster drug Keytruda contributed $29.48 billion in sales in 2024, but the first of its patent expirations begins in 2028.
On World Cancer Day: City of Hope Offers 10 Bold Solutions to End Cancer
City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World ...
The reason young women’s bodies are more prone to cancer
Cancer is affecting increasing numbers of young women with the hormone oestrogen thought to play to a central role ...
Cancer patient's treatment was delayed - coroner
A coroner found there were "missed opportunities" to treat a 38-year-old woman with cancer. Carla Smith, 38, who died on 7 ...